270
Participants
Start Date
May 31, 2001
Study Completion Date
January 31, 2005
Single-injection femoral nerve block
Nerve block bolus with 30 mL levobupivacaine 0.25%, followed by continuous saline infusion
Femoral nerve block 60-hour continuous injection
Nerve block bolus with 30 mL levobupivacaine 0.25%, followed by continuous infusion (5 mL/hr for 50 hours) of 0.25% levobupivacaine
Saline (control) injection into femoral nerve envelope
Nerve block bolus with 30 mL saline, followed by continuous saline infusion
University of Pittsburgh Medical Center, Center for Sports Medicine, Pittsburgh
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
University of Pittsburgh
OTHER